Page last updated: 2024-08-25

3-deazaneplanocin and Cancer of Head

3-deazaneplanocin has been researched along with Cancer of Head in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Endo-Munoz, L; Gannon, OM; Hazar-Rethinam, M; Merida de Long, L; Saunders, NA	1

Other Studies

1 other study(ies) available for 3-deazaneplanocin and Cancer of Head

Article	Year
Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation. Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Jan-15, Volume: 19, Issue:2 Topics: Adenosine; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Histones; Humans; Methylation; Mice; Polycomb Repressive Complex 2; RNA Interference; Squamous Cell Carcinoma of Head and Neck; Transplantation, Heterologous	2013

Article

Year

Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Jan-15, Volume: 19, Issue:2

Topics: Adenosine; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Histones; Humans; Methylation; Mice; Polycomb Repressive Complex 2; RNA Interference; Squamous Cell Carcinoma of Head and Neck; Transplantation, Heterologous

2013